Last Updated: May 3, 2026

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lidocaine Hydrochloride Preservative Free patents expire, and what generic alternatives are available?

Lidocaine Hydrochloride Preservative Free is a drug marketed by Eugia Pharma, Extrovis, Fresenius Kabi Usa, Hikma, Hospira, and Intl Medication. and is included in nine NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride Preservative Free

A generic version of LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18th, 1982.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE?
  • What are the global sales for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE?
  • What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE?
Summary for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
US Patents:0
Applicants:6
NDAs:9

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 203040-001 Mar 14, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 017584-002 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eugia Pharma LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 203082-002 Mar 14, 2013 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 088295-001 May 17, 1984 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 084625-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 040302-002 Sep 28, 1998 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links